332
Views
16
CrossRef citations to date
0
Altmetric
Review

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update

, , &
Pages 631-642 | Published online: 29 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stylianos Arseniou, Vasileios Siokas, Athina-Maria Aloizou, Polyxeni Stamati, Alexios-Fotios A. Mentis, Zisis Tsouris, Metaxia Dastamani, Eleni Peristeri, Varvara Valotassiou, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou & Efthimios Dardiotis. (2020) SLC2A3 rs12842 polymorphism and risk for Alzheimer’s disease. Neurological Research 42:10, pages 853-861.
Read now

Articles from other publishers (15)

Lijing Wang, Huiyan Yu, Ling Hao, Mengwei Ju, Wenjing Feng & Rong Xiao. (2023) The Interaction Effect of 27‐Hydroxycholesterol Metabolism Disorder and CYP27A1 Single Nucleotide Polymorphisms in Mild Cognitive Impairment: Evidence from a Case–Control Study. Molecular Nutrition & Food Research.
Crossref
Arash Rezaeirad, ÖmerFaruk Karasakal, EbruÖzkan Oktay & Mesut Karahan. (2023) In silico evaluation of single-nucleotide polymorphisms in CHRNA7 and GRIN1 genes related to Alzheimer's disease. The Journal of Neurobehavioral Sciences 10:1, pages 22.
Crossref
Saba Abdi, Amani Ahmed Alghamdi, Nouf Nasser Abduallah AlGhunaim, Reem Muteb Almutairi, Farid Shokry Ataya, Mohammed Ghouse Ahmed Ansari, Syed Danish Hussain, Mohammad Masoud, Abir Alamro, Othman T. Almutairi, Nasser M. Al-Daghri & Taim Abdullah Muayqil. (2022) Association of Alzheimer’s Disease with Genetic Variants of Apolipoprotein E, Clusterin, TNF-α, and IL-6 Among Elderly Saudis. Current Pharmaceutical Biotechnology 23:15, pages 1893-1902.
Crossref
Solmaz Mohammadi, Javad Mahmoudi, Fereshteh Farajdokht, Milad Asadi, Parya Pirsarabi, Seyedeh Farrokh Kazeminiaei, Sepideh Parvizpour & Saeed Sadigh-Eteghad. (2022) Polymorphisms of nicotinic acetylcholine receptors in Alzheimer’s disease: a systematic review and data analysis. Egyptian Journal of Medical Human Genetics 23:1.
Crossref
Federico Emanuele Pozzi, Elisa Conti, Ildebrando Appollonio, Carlo Ferrarese & Lucio Tremolizzo. (2022) Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review. Frontiers in Neuroscience 16.
Crossref
Johanna Alexandra Tejada Moreno, Andrés Villegas Lanau, Lucia Madrigal Zapata, Ana Yulied Baena Pineda, Juan Velez Hernandez, Omer Campo Nieto, Alejandro Soto Ospina, Pedronel Araque Marín, Lavanya Rishishwar, Emily T. Norris, Aroon T. Chande, I. King Jordan & Gabriel Bedoya Berrio. (2022) Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer’s disease in a multigenerational Colombian Family. PLOS ONE 17:7, pages e0269955.
Crossref
Ghazal Mirabnahrazam, Da Ma, Sieun Lee, Karteek Popuri, Hyunwoo Lee, Jiguo Cao, Lei Wang, James E. Galvin & Mirza Faisal Beg. (2022) Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer’s Disease. Journal of Alzheimer's Disease 87:3, pages 1345-1365.
Crossref
Md. Abdul Aziz, Ghulam Md Ashraf & Mohammad Safiqul Islam. (2022) Link of BIN1, CLU, and IDE Gene Polymorphisms with the Susceptibility of Alzheimer’s Disease: Evidence from a Meta-analysis. Current Alzheimer Research 19:4, pages 302-316.
Crossref
Anna Morozova, Yana Zorkina, Olga Abramova, Olga Pavlova, Konstantin Pavlov, Kristina Soloveva, Maria Volkova, Polina Alekseeva, Alisa Andryshchenko, Georgiy Kostyuk, Olga Gurina & Vladimir Chekhonin. (2022) Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. International Journal of Molecular Sciences 23:3, pages 1217.
Crossref
Daniel T. Infield, Kerry M. Strickland, Amit Gaggar & Nael A. McCarty. (2021) The molecular evolution of function in the CFTR chloride channel. Journal of General Physiology 153:12.
Crossref
Amalia Cecilia Bruni, Livia Bernardi & Raffaele Maletta. (2021) Evolution of genetic testing supports precision medicine for caring Alzheimer's disease patients. Current Opinion in Pharmacology 60, pages 275-280.
Crossref
Veer B. Gupta, Nitin Chitranshi, Jurre den Haan, Mehdi Mirzaei, Yuyi You, Jeremiah KH. Lim, Devaraj Basavarajappa, Angela Godinez, Silvia Di Angelantonio, Perminder Sachdev, Ghasem H. Salekdeh, Femke Bouwman, Stuart Graham & Vivek Gupta. (2021) Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances. Progress in Retinal and Eye Research 82, pages 100899.
Crossref
Tuba EGE & Hayriye ŞELİMEN. (2021) Monoamine Oxidase Inhibitory Effects of Medicinal Plants in Management of Alzheimer's Disease. Journal of the Turkish Chemical Society Section A: Chemistry 8:1, pages 239-248.
Crossref
Sara Redenšek & Vita Dolžan. (2020) The role of pharmacogenomics in the personalization of Parkinson's disease treatment. Pharmacogenomics 21:14, pages 1033-1043.
Crossref
Yi-Yuan Tang & Rongxiang Tang. 2020. The Neuroscience of Meditation. The Neuroscience of Meditation 65 83 .